PuSH - Publikationsserver des Helmholtz Zentrums München

Koch, M.* ; Freitag-Wolf, S.* ; Schlesinger, S.* ; Borggrefe, J.* ; Hov, J.R.* ; Jensen, M.K.* ; Pick, J.* ; Markus, M.R.* ; Höpfner, T.* ; Jacobs, G.* ; Siegert, S.* ; Artati, A. ; Kastenmüller, G. ; Römisch-Margl, W. ; Adamski, J. ; Illig, T.* ; Nothnagel, M.* ; Karlsen, T.H.* ; Schreiber, S.* ; Franke, A.* ; Krawczak, M.* ; Nöthlings, U.* ; Lieb, W.*

Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample.

Eur. J. Clin. Nutr. 71, 995–1001 (2017)
Verlagsversion Forschungsdaten DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND/OBJECTIVES: Fatty liver disease (FLD) is an important intermediate trait along the cardiometabolic disease spectrum and strongly associates with type 2 diabetes. Knowledge of biological pathways implicated in FLD is limited. An untargeted metabolomic approach might unravel novel pathways related to FLD. SUBJECTS/METHODS: In a population-based sample (n=555) from Northern Germany, liver fat content was quantified as liver signal intensity using magnetic resonance imaging. Serum metabolites were determined using a non-targeted approach. Partial least squares regression was applied to derive a metabolomic score, explaining variation in serum metabolites and liver signal intensity. Associations of the metabolomic score with liver signal intensity and FLD were investigated in multivariable-adjusted robust linear and logistic regression models, respectively. Metabolites with a variable importance in the projection >1 were entered in in silico overrepresentation and pathway analyses. RESULTS: In univariate analysis, the metabolomics score explained 23.9% variation in liver signal intensity. A 1-unit increment in the metabolomic score was positively associated with FLD (n=219; odds ratio: 1.36; 95% confidence interval: 1.27-1.45) adjusting for age, sex, education, smoking and physical activity. A simplified score based on the 15 metabolites with highest variable importance in the projection statistic showed similar associations. Overrepresentation and pathway analyses highlighted branched-chain amino acids and derived gamma-glutamyl dipeptides as significant correlates of FLD. CONCLUSIONS: A serum metabolomic profile was associated with FLD and liver fat content. We identified a simplified metabolomics score, which should be evaluated in prospective studies.European Journal of Clinical Nutrition advance online publication, 5 April 2017; doi:10.1038/ejcn.2017.43.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.057
0.000
11
16
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Hepatic Steatosis; Disease; Progression; Patterns; Metaboanalyst; Biomarkers; Systems; Risk; Tool
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 0954-3007
e-ISSN 1476-5640
Quellenangaben Band: 71, Heft: 8, Seiten: 995–1001 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
POF Topic(s) 30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
Forschungsfeld(er) Enabling and Novel Technologies
Genetics and Epidemiology
PSP-Element(e) A-630710-001
G-503891-001
G-505600-003
G-503700-001
Scopus ID 85017138983
PubMed ID 28378853
Erfassungsdatum 2017-06-08